Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$0.31 - $0.55 $339 - $602
-1,095 Reduced 83.72%
213 $0
Q1 2023

May 12, 2023

SELL
$0.32 - $1.88 $733 - $4,308
-2,292 Reduced 63.67%
1,308 $0
Q4 2022

Feb 09, 2023

SELL
$0.35 - $20.75 $3,935 - $233,313
-11,244 Reduced 75.75%
3,600 $1,000
Q3 2022

Nov 09, 2022

SELL
$0.83 - $21.25 $9,593 - $245,628
-11,559 Reduced 43.78%
14,844 $10,000
Q2 2022

Aug 11, 2022

SELL
$1.12 - $2.18 $45,623 - $88,802
-40,735 Reduced 60.67%
26,403 $34,000
Q1 2022

May 12, 2022

BUY
$1.63 - $3.63 $101,997 - $227,147
62,575 Added 1371.36%
67,138 $180,000
Q4 2021

Feb 11, 2022

SELL
$2.25 - $4.11 $6,239 - $11,397
-2,773 Reduced 37.8%
4,563 $10,000
Q3 2021

Nov 12, 2021

BUY
$2.71 - $5.9 $19,880 - $43,282
7,336 New
7,336 $30,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.